Ozempic's list price is $935/month — but most people pay far less, and some pay nothing.
Key Takeaways
- List price: $935.77/month without insurance in 2026 — $11,229/year
- With commercial insurance: Copays range from $25–$150/month depending on plan tier
- Novo Nordisk Savings Card: Pay as little as $25/month for up to 48 months (commercial insurance required)
- NovoCare direct-pay: $499/month self-pay for any dose, no insurance needed
- New in 2026 — TrumpRx: Direct platform offering ~$199–$350/month for cash-pay patients
- Medicare CMS pilot (mid-2026): Select Part D beneficiaries can access Ozempic for $35–$50/month
- Compounded semaglutide: $100–$300/month through telehealth (regulatory status shifting)
- Research-grade S-5 (Ascension Peptides): As low as $44 per 5mg vial — the lowest-cost option
- Generic semaglutide: Blocked by patents until 2031–2032
2026 is genuinely different for Ozempic costs. Novo Nordisk slashed prices for insured patients by up to 50%, launched a $499/month self-pay program through NovoCare, and a new government-backed platform (TrumpRx) now connects cash-pay patients to discounted rates. This guide covers every option — from the best insurance tricks to the cheapest research peptide alternative — with real 2026 pricing throughout.
What Does Ozempic Cost Without Insurance in 2026?
The wholesale acquisition cost (WAC) for Ozempic is $935.77 per month — the same across all pen strengths (0.25/0.5 mg, 1 mg, and 2 mg). Novo Nordisk has held this list price steady since 2023 under political pressure. Retail pharmacies typically mark it up to $950–$1,100/month.
| Ozempic Pen | Retail Price (No Insurance) | Supply |
|---|---|---|
| 0.25 mg / 0.5 mg starter pen | $950–$1,000 | 4 weeks |
| 1 mg pen | $960–$1,050 | 4 weeks |
| 2 mg pen | $960–$1,100 | 4 weeks |
The annual cost at list price: $11,229 or more. That makes affordability strategies — not just awareness — the most valuable thing this article can give you.
Why Is Ozempic So Expensive?
Novo Nordisk holds multiple patents on semaglutide — the molecule itself, the delivery device, and the formulation. Those patents block generics until 2031–2032. Meanwhile, massive demand from off-label weight loss use has kept supply tight and Novo Nordisk's incentive to lower prices minimal. The politics around drug pricing in 2026 have pushed Novo Nordisk to offer more programs — but the list price itself hasn't dropped.
Ozempic Cost With Insurance in 2026
If you have commercial health insurance and a type 2 diabetes diagnosis, Ozempic is one of the most reliably covered GLP-1 medications. Your copay depends on formulary tier, deductible status, and whether you stack the Novo Nordisk Savings Card.
Commercial Insurance Copays
| Insurance Scenario | Typical Monthly Cost | Notes |
|---|---|---|
| Preferred formulary (Tier 2) | $25–$50 | Best case — plan prefers Ozempic |
| Non-preferred brand (Tier 3) | $50–$95 | Most common in 2026 after tier shifts |
| Specialty tier (Tier 4–5) | $100–$150+ | Higher coinsurance until out-of-pocket max |
| High-deductible plan (pre-deductible) | $400–$800 | Drops sharply once deductible is met |
| Not covered / excluded | $935+ (full price) | Many plans exclude GLP-1s for weight loss only |
2026 update: Novo Nordisk announced cuts of approximately 50% to Ozempic's price for insured patients who pay based on list price — meaning your effective copay and coinsurance calculations may be lower than expected. Confirm with your pharmacy.
Medicare Part D Coverage in 2026
Medicare Part D covers Ozempic for FDA-approved indications: type 2 diabetes, cardiovascular risk reduction, and chronic kidney disease. Weight-loss-only prescriptions are excluded by federal law.
- Standard Part D copay: $35–$150/month depending on plan tier and deductible
- After $2,000 annual cap (IRA): $0 for the rest of the year — millions hit this threshold
- Extra Help (Low-Income Subsidy): $0–$11.20/month with no deductible; over 1.6 million Ozempic users qualify
- New CMS pilot (launching mid-2026): Select Part D enrollees with combined diabetes/obesity management can access Ozempic for $35–$50/month even before deductible. Limited enrollment — ask your Medicare plan if you're eligible
Medicaid Coverage
Medicaid covers Ozempic in all 50 states for type 2 diabetes, with copays of $0–$4/month. As of 2026, only 18 states cover it for obesity alone. Dual-eligible (Medicare + Medicaid) patients typically pay nothing. Approval rate exceeds 90% with proper documentation.
Tips for Getting Insurance to Cover Ozempic
- Diabetes diagnosis is your ticket — coverage is far more common for T2D than weight loss alone
- Request prior authorization proactively — many plans require it but approve quickly with doctor documentation
- Appeal denials — submit supporting records; approval rates are high on first appeal
- Check if your plan moved Ozempic to Tier 3 — many major insurers did this in 2025–2026
Novo Nordisk Savings Card: Ozempic for $25/Month
The Novo Nordisk savings card reduces your Ozempic copay to $25 per month for up to 48 months. This is the single best deal for commercially insured patients.
Eligibility Requirements
- Must have commercial (private) health insurance that covers Ozempic
- Cannot use with Medicare, Medicaid, Tricare, or other government-funded plans
- Maximum savings of $225–$525 per fill depending on state
- Valid for up to 48 monthly fills (updated from the prior 24-month limit)
How to Get the Card
- Go to Ozempic.com and find the savings section
- Complete the eligibility form — takes about 5 minutes
- Get your digital card instantly
- Present it at your pharmacy alongside your insurance
Pro tip: The savings card stacks with your insurance. Your insurer pays their portion; the card covers most or all of your remaining copay. If your copay is already under $25, the card won't reduce it further — but it will extend coverage for up to 48 months.
New in 2026: TrumpRx and NovoCare Direct-Pay
Two new self-pay options launched in late 2025 and early 2026 that significantly change the math for uninsured patients.
TrumpRx
TrumpRx is a government-backed direct-to-consumer platform that simplifies access to manufacturer discount programs. It doesn't sell drugs directly, but connects uninsured or underinsured patients to Novo Nordisk and Eli Lilly pricing programs. Expected monthly cost for Ozempic through TrumpRx: $199–$350/month for cash-pay patients.
NovoCare Pharmacy Direct
Novo Nordisk's own mail-order pharmacy offers Ozempic at $499/month for any dose, with free shipping. No insurance required — cash pay only. This is currently the most straightforward self-pay option if you don't qualify for assistance programs. (Introductory pricing of $299/month was available through early 2026; check current rates.)
| Self-Pay Option | Monthly Cost | Notes |
|---|---|---|
| NovoCare Pharmacy direct | $499 | Any dose, free shipping, no insurance |
| TrumpRx platform | ~$199–$350 | Government-backed, connects to manufacturer discounts |
| GoodRx / SingleCare coupons | $850–$920 | Modest savings, works at any pharmacy |
| Costco cash pay | ~$499–$550 | Member pricing, sometimes matches NovoCare |
Patient Assistance Program: Free Ozempic
Novo Nordisk's Patient Assistance Program (PAP) provides Ozempic at no cost for qualifying uninsured or underinsured patients. Approval rate exceeds 95% for eligible applicants.
Requirements
- U.S. resident with a valid Ozempic prescription
- No prescription drug coverage, or coverage that doesn't include Ozempic
- Household income at or below 400% of the Federal Poverty Level (~$60,000/year for a single person in 2026)
- Must reapply every 12 months
How to Apply
- Visit NovoCare.com or call 1-866-310-7549
- Download and complete the application
- Have your doctor sign the prescription section
- Submit proof of income (tax return, pay stubs, or benefit statements)
- If approved (2–4 weeks), Ozempic ships directly to you at no charge
Bridge tip: Processing takes 2–4 weeks. Ask your doctor for sample pens to cover the gap while your application is reviewed.
Compounded Semaglutide in 2026: Still Available, But Watch the Rules
Compounded semaglutide exploded during the 2024–2025 shortage, offering the same active ingredient at $100–$300/month through telehealth platforms. The shortage has since resolved, and Novo Nordisk has pushed back on compounders — but many are still operating.
Current Status
The FDA declared semaglutide no longer in shortage in late 2024. This affects 503A compounding pharmacies (which can only compound when a shortage exists), but 503B outsourcing facilities have more flexibility. The legal landscape is evolving — check current regulatory status with any telehealth provider before committing.
Telehealth Platform Pricing
| Platform | Monthly Cost | What's Included |
|---|---|---|
| Hims / Hers | $199–$299 | Consultation + medication + shipping |
| Ro (Roman) | $149–$249 | Provider visit + compounded semaglutide |
| Henry Meds | $199–$297 | Medication + quarterly provider visits |
| Local 503B pharmacy | $100–$200 | Prescription required, no consult included |
Before you order: Ask your telehealth provider specifically whether they use a 503B outsourcing facility (stricter FDA oversight) or a 503A pharmacy. With the shortage resolved, 503A compounding of semaglutide is legally uncertain. Insurance won't cover compounded versions regardless.
Research-Grade Semaglutide (S-5): The Lowest-Cost Option
For those who want semaglutide at the lowest possible price and are comfortable with self-administration, Ascension Peptides' S-5 — lyophilized semaglutide at $44 per 5mg vial — is the most affordable option on the market.
Ascension Peptides S-5 (Semaglutide 5mg) — $44/vial
Third-party tested, 5mg lyophilized semaglutide. Ships quickly, COA available.
Check Current Price at Ascension Peptides →
S-5 Cost vs. Every Other Option
| Source | Monthly Cost | Annual Cost | Rx Required? |
|---|---|---|---|
| Ozempic (retail, no insurance) | $935–$1,100 | $11,229+ | Yes |
| Ozempic (insurance + savings card) | $25–$150 | $300–$1,800 | Yes |
| NovoCare direct-pay | $499 | $5,988 | Yes |
| TrumpRx | $199–$350 | $2,388–$4,200 | Yes |
| Compounded semaglutide (telehealth) | $100–$300 | $1,200–$3,600 | Yes (telehealth) |
| S-5 (Ascension Peptides) | ~$44–$88 | ~$528–$1,056 | No |
At $44 per 5mg vial, research-grade semaglutide costs roughly 95% less than brand Ozempic and 50–75% less than compounded telehealth alternatives. The trade-off: you reconstitute the powder yourself rather than receiving a pre-filled pen.
What to Know About S-5
- Lyophilized powder: Reconstitute with bacteriostatic water before injecting
- Third-party tested: Ascension Peptides provides certificates of analysis (COA) with 98%+ purity
- Storage: Refrigerate after reconstitution; use within 4–6 weeks
- Dosing flexibility: A single 5mg vial covers 5+ weeks at the 1mg/week maintenance dose; significantly longer at the 0.25mg starter dose
- Titration: Standard schedule is 0.25mg → 0.5mg → 1mg → 2mg/week
Full Cost Comparison: Every Semaglutide Option in 2026
| Option | Monthly Cost | Pros | Cons |
|---|---|---|---|
| Ozempic (retail, no insurance) | $935–$1,100 | FDA-approved, pre-filled pen | Extremely expensive |
| Ozempic (insurance + savings card) | $25 | Lowest cost for brand-name, 48-month term | Commercial insurance only |
| NovoCare direct-pay | $499 | No insurance needed, any dose | Still pricey vs. alternatives |
| TrumpRx | ~$199–$350 | Simplified access, government-backed | Still requires Rx |
| GoodRx / coupons | $850–$920 | No insurance needed | Minimal savings vs. retail |
| Patient Assistance Program | $0 | Free if you qualify | Income limits, 2–4 week wait |
| Compounded semaglutide | $100–$300 | Same ingredient, includes consult | Regulatory uncertainty, cash-only |
| S-5 (Ascension Peptides) | ~$44–$88 | Lowest cost, third-party tested | Self-reconstitution required |
Ozempic vs. Other GLP-1 Medications: Cost Comparison
| Medication | Active Ingredient | Monthly Cost (No Insurance) | Indication |
|---|---|---|---|
| Ozempic | Semaglutide | $935 | Type 2 diabetes |
| Wegovy (injection) | Semaglutide (higher dose) | $1,349 → $199 (NovoCare) | Weight management |
| Wegovy (oral pill) | Semaglutide | ~$149–$150 (starting dose) | Weight management (FDA-approved Dec 2025) |
| Mounjaro | Tirzepatide | $1,023 | Type 2 diabetes |
| Zepbound | Tirzepatide | $349–$499 (LillyDirect) | Weight management |
| Rybelsus | Semaglutide (oral) | $935 | Type 2 diabetes |
Notable 2026 update: Oral Wegovy — the first GLP-1 weight loss pill — received FDA approval in December 2025. Starting-dose pricing is around $149/month through NovoCare, making it the most accessible brand-name semaglutide option for weight management.
How to Save the Most on Ozempic: Step-by-Step
Step 1: Check Your Insurance Formulary
Call your insurer and ask: "Is semaglutide (Ozempic) on my formulary, and what tier?" Tier 2 = low copay. Tier 3 = higher, but the savings card can close the gap.
Step 2: Apply for the Savings Card Immediately
If you have commercial insurance, apply at Ozempic.com before your first fill. The card brings your cost to $25/month for up to 48 months.
Step 3: If Uninsured — Try NovoCare or TrumpRx First
NovoCare's $499/month direct program is the easiest self-pay option. TrumpRx may get you to $199–$350. Try these before paying retail.
Step 4: Check PAP Eligibility
If your income is below 400% FPL (~$60,000/year), apply for free Ozempic through NovoCare. It takes 2–4 weeks but costs you nothing.
Step 5: Consider Compounded Semaglutide (With Eyes Open)
Telehealth compounded semaglutide at $100–$300/month is a solid middle ground — but verify your provider uses a 503B outsourcing facility given the changed shortage status.
Step 6: Explore Research Peptides for the Lowest Price
If you're comfortable with self-administration and want the lowest possible cost, Ascension Peptides' S-5 at $44/vial already undercuts what generics will likely cost when patents expire in 2031.
When Will Generic Ozempic Be Available?
| Patent Type | Expected Expiration | Impact |
|---|---|---|
| Core semaglutide molecule | 2031–2032 | Enables generic injectable versions |
| Formulation patents | 2033–2034 | May delay exact pen device copies |
| Oral semaglutide (Rybelsus/Wegovy pill) | 2034+ | Oral generic likely delayed further |
Based on historical biosimilar patterns, generic injectable semaglutide will probably cost 40–70% less than brand-name — roughly $280–$560/month. Medicare price negotiations (expanding in 2027–2028) could push it lower. But for now, research peptides at $44–$88/month already beat what generics will likely cost.
International Ozempic Prices vs. U.S.
| Country | Monthly Cost (USD equivalent) | vs. U.S. List Price |
|---|---|---|
| United States | $935 | Baseline |
| Canada | $250–$350 | ~63–73% less |
| United Kingdom | $75–$100 (NHS) | ~89–92% less |
| Germany | $120–$180 | ~81–87% less |
| Mexico | $150–$250 | ~73–84% less |
| India | $80–$130 | ~86–91% less |
Purchasing a 90-day personal supply from Canadian or Mexican pharmacies is technically a legal gray area but generally tolerated by the FDA. Verify pharmacy legitimacy through CIPA (Canada) or COFEPRIS (Mexico) certification before ordering.
Hidden Costs to Factor In
Injectable Supplies (Compounded or Research Peptide Only)
If you're not using the pre-filled Ozempic pen, budget roughly $5–$10/month for:
- Bacteriostatic water — $5–$10/vial
- Insulin syringes — $10–$15 per 100-count box
- Alcohol swabs — $3–$5/box
- Sharps container — $5–$10 (one-time)
Monitoring and Doctor Visits
- A1C test every 3–6 months if diabetic
- Annual metabolic panel (baseline recommended regardless of source)
- Periodic thyroid monitoring — semaglutide carries a boxed warning for thyroid C-cell tumors
Semaglutide Dosing Schedule and How It Affects Cost
| Week | Dose | Purpose |
|---|---|---|
| Weeks 1–4 | 0.25 mg/week | Starter dose — minimize GI side effects |
| Weeks 5–8 | 0.5 mg/week | Therapeutic dose for diabetes |
| Weeks 9–12 | 1 mg/week | Full dose for most patients |
| Week 13+ | 2 mg/week (optional) | Maximum dose for additional efficacy |
At the starter 0.25mg dose, a single S-5 vial from Ascension Peptides covers 20+ weeks. Even at the 1mg maintenance dose, one vial equals 5 weeks of supply — making the research peptide route dramatically cheaper than any other option.
Is Ozempic Worth the Cost?
The clinical data is strong: semaglutide achieves 14–15% body weight reduction over 68 weeks in clinical trials, with significant A1C improvements for diabetics and cardiovascular benefits confirmed in the SELECT trial. Whether it's worth the monthly spend depends entirely on what you're paying:
- $25/month (insurance + savings card): Absolutely worth it for most people with T2D or obesity
- $199–$499/month (NovoCare/TrumpRx): Good value if you need convenience and don't qualify for assistance
- $100–$300/month (compounded): Reasonable middle ground, verify 503B status
- $44–$88/month (research peptides): Best per-dollar value for those comfortable with self-administration
- $935+/month (retail, no programs): Hard to justify when so many cost-reduction paths exist
For a full breakdown of what to expect physically, see our guide on Ozempic side effects — how common each is and when they resolve.
Frequently Asked Questions
How much does Ozempic cost per month without insurance in 2026?
The list price is $935.77/month for all pen strengths. Retail pharmacies charge $950–$1,100 after markup. GoodRx brings it to $850–$920, NovoCare charges $499/month, and TrumpRx offers ~$199–$350 for qualifying patients.
Does insurance cover Ozempic for weight loss?
Most plans cover Ozempic for type 2 diabetes but not weight loss alone. Wegovy (including the new oral pill approved December 2025) is the FDA-approved weight management option. Some plans cover it with prior authorization, especially with an obesity (BMI 30+) diagnosis.
How long does the Novo Nordisk savings card last?
As of 2026, the Novo Nordisk savings card covers up to 48 monthly fills (upgraded from the prior 24-month limit), reducing your copay to as little as $25/month. Requires commercial insurance that covers Ozempic — does not work with Medicare, Medicaid, or government-funded plans.
What is TrumpRx and how does it affect Ozempic pricing?
TrumpRx is a government-backed direct-to-consumer platform that connects uninsured or underinsured patients to manufacturer discount programs for GLP-1 medications including Ozempic. Expected pricing is $199–$350/month for cash-pay patients — significantly lower than retail but more than the PAP or savings card.
Is compounded semaglutide still legal in 2026?
It's complicated. The FDA declared semaglutide no longer in shortage in late 2024, which affects 503A compounding pharmacies (which require a shortage to legally compound). 503B outsourcing facilities operate under different rules. Many telehealth platforms continue offering compounded semaglutide — ask specifically whether your provider uses a 503B facility, and check current regulatory status before ordering.
What is S-5 from Ascension Peptides?
S-5 is research-grade semaglutide sold in 5mg lyophilized vials for $44 each. It's third-party tested with a certificate of analysis verifying 98%+ purity. You reconstitute it with bacteriostatic water and inject weekly — the same active compound as Ozempic at roughly 95% less cost per dose.
When will generic Ozempic be available?
Novo Nordisk's core semaglutide patents expire 2031–2032. Generic injectable versions could follow, though formulation patents extend to 2033–2034. Medicare price negotiations expanding in 2027–2028 may push brand pricing down before generics arrive.
Can I buy Ozempic from Canada to save money?
Ozempic costs $250–$350/month in Canada vs. $935+ in the U.S. A 90-day personal supply from a CIPA-certified Canadian pharmacy is generally tolerated by the FDA for personal use, though technically not FDA-approved. Verify pharmacy legitimacy before purchasing.
Does GoodRx work for Ozempic?
Yes — GoodRx brings retail prices to $850–$920/month, saving $35–$110 off list. Useful as a short-term bridge or if you're between insurance plans, but NovoCare's $499 direct-pay program is a better cash-pay option in 2026.
What is the new oral Wegovy pill?
The FDA approved oral Wegovy (semaglutide pill) in December 2025 for weight management in adults with BMI 30+ or overweight with a related condition. Starting doses cost approximately $149/month through NovoCare — the most accessible branded semaglutide option for weight loss without injection.
References
- Wilding JPH, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." New England Journal of Medicine. 2021;384(11):989-1002. PubMed
- Marso SP, et al. "Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes." New England Journal of Medicine. 2016;375(19):1834-1844. PubMed
- Lincoff AM, et al. "Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes." New England Journal of Medicine. 2023;389(24):2221-2232. PubMed
- Davies MJ, et al. "Semaglutide 2.4 mg once a week in adults with overweight or obesity (STEP 2)." The Lancet. 2021;397(10278):971-984. PubMed
- Rubino D, et al. "Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance." JAMA. 2021;325(14):1414-1425. PubMed
- U.S. Food and Drug Administration. "FDA Drug Shortages — Semaglutide." FDA.gov
- NBC News. "Weight loss drug prices in 2026: GLP-1 pills, TrumpRx." nbcnews.com
- AARP. "Weight Loss Drugs Price Drop — TrumpRx." aarp.org
The information in this article is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting any new supplement or compound. Results vary by individual.
